On-Demand Webinar

Bioactive Lipids in MASH Pathogenesis

About the webinar:

Dr. Harmeet Malhi joined Taconic Biosciences as a featured speaker at the virtual MASH (formerly NASH) Symposium.

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a complex spectrum of disorders ranging from simple benign steatosis to steatohepatitis (MASH) with fibrosis. MASLD is increasingly common around the world, especially in Western nations. 

In this presentation, you will get a better understanding on the various classes of lipids that may mediate toxicity and identify actionable signaling pathways that may be therapeutic targets in MASH.

Dr. Harmeet Malhi presents on related extracellular Vesicles (EVs), emerging mediators of intercellular communication in MASH.

 

Speaker

Harmeet Malhi, MBBS  LinkedIn
Professor of Medicine and Physiology
Mayo Clinic

Janell Richardson

Dr. Harmeet Malhi is Professor of Medicine and Physiology at Mayo Clinic. She attended medical school at the University College of Medical Sciences in New Delhi, India. Her research interest is in mechanisms of liver injury and inflammation with a specific focus on nonalcoholic steatohepatitis pathogenesis, including biomarker development in nonalcoholic and alcoholic steatohepatitis.

Dr. Malhi currently serves as a deputy editor for Hepatology and on the editorial board of Hepatology Communications. She has published over 90 peer-reviewed manuscripts, editorials and book chapters and has served as a reviewer for numerous journals, including Hepatology and the Journal of Lipid Research.

Dr. Malhi is the principal investigator of two NIH grants and several foundation grants. She is on study section for the American Liver Foundation, AGA, AASLD, and a standing member of Hepatobiliary Pathophysiology study section of the Center for Scientific Review, NIH. Intramurally, she serves as Associate Chair for Research in the Division.

View the Webinar